Skip to main content
Caplight Logo









Weavrcare

Weavrcare

Private
SeoulHealthcare & Life Scienceshttps://weavr.care/

Last Round

Series A

Dec 2, 2020

Total Funding Raised

$3.65M

Company Overview

Weavrcare is a healthcare technology company that provides digital solutions for medical institutions, including cloud-based electronic medical record (EMR) systems and patient-centered health data platforms.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Vertical SaaS, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

electronic medical recordEMRcloud-based EMREHRhealthtechclinic management systempatient engagementhospital management softwarevertical SaaSpatient portalhealth information platformclinical workflowmedical data managementdigital healthmedical tourism

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Weavrcare Comparables

Compare Weavrcare with similar companies based on industry and business-model similarity.

Weavrcare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
UBcare. Co. Ltd
80%
Naver Corporation
78%
Easethetics
77%

Weavrcare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 2, 2020

Key People

Founding team and executive leadership

Eunsol Lee

Co-Chief Executive Officer, Chief Executive Officer

Executive Team

Minkyoo Cha

CTO

Executive Team

SEUNGCHAN PARK

Chief Financial Officer

Executive Team

박승찬

Chief Financial Officer

Executive Team

Weavrcare Investors

Notable investors and investment history

Weavrcare investors
InvestorRounds
NAVER D2SFSeries A
Company K PartnersSeries A
IMM InvestmentSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors grew 119% MoM, reaching 10.6K.

  • Nov 12, 2025

    Monthly visitors increased 32% MoM.

Weavrcare Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Weavrcare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Weavrcare's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range45
Year Founded2017
Last FundingDec 2, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?